510(k) K230651
K230651 is an FDA 510(k) premarket notification submitted by Becton, Dickinson and Company for the device "BD BBL Sensi-Disc Lefamulin 20µg (LMU-20)". The FDA issued a decision of Substantially Equivalent on June 7, 2023. The device falls under product code JTN (Susceptibility Test Discs, Antimicrobial), a Class II device regulated under 21 CFR 866.1620. Becton, Dickinson and Company has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 7, 2023
- Date Received
- March 9, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Susceptibility Test Discs, Antimicrobial
- Device Class
- Class II
- Regulation Number
- 866.1620
- Review Panel
- MI
- Submission Type